New hope for advanced bile duct cancer patients
Disease control
Recruiting now
This study is gathering more information on the safety and effectiveness of the drug ivosidenib for adults with advanced bile duct cancer (cholangiocarcinoma) who have already tried at least one other treatment. All participants will take ivosidenib pills daily. The main goal is …
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC